Stonvex
Discover
  • Dashboard
  • World News
  • Stock News
  • Rankings
  • Quant Picks
  • Screener
Markets
  • Heatmap
  • Gainers & Losers
Tools
  • Compare
  • Calendar
  • Community
HomeRankingsScreenerPortfolioCommunity
Stonvex
Log inGet Started
← Back to search

JBIO

Live
Real-time chart · IB-grade AI research · Polygon.io data feed
Set alertSave
  • Overview
  • Financials
  • Filings
  • Short Interest
  • Ownership
  • Ratings
  • Peers
  • Options
  • News
✦
Stonvex AI

JBIO

AI Research Report

Powered by Claude

Ready to analyze JBIO

Runs the full IB-grade framework: Narrative, Reverse DCF, Comps, Sensitivity, and Deal Radar. Takes 20–40 seconds.

Free preview · 3 reports / hour · No sign-up required

Earnings

Next report date, year-over-year trend, and recent quarter history.

Earnings history activates with Polygon. When configured, this panel shows the next report date, consensus EPS/revenue, and the last 4 quarters of actual-vs-estimate.

Quant Grades

6-factor scoring with sector-relative rank. Updated daily.

Quant grades are available for tickers in our scored universe.

Financial statements

Most recent quarterly filings sourced directly from SEC EDGAR.

Financial statements activate with Polygon. The Developer plan includes quarterly and annual filings sourced directly from SEC EDGAR.

Corporate events

Share this analysis

Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.

Stonvex

AI-powered stock research for US equities.

whgksdhr1111@naver.com

Product

  • Rankings
  • Quant Picks
  • Screener
  • Markets
  • Compare
  • Calendar

Company

  • About Stonvex
  • Pricing & Plans
  • Community
  • Help & FAQ
  • Contact Us

Legal

  • Terms of Service
  • Privacy Policy
  • Privacy Consent
  • Disclaimer
  • Notices & Updates

© 2026 Stonvex. All rights reserved.

This site is for informational purposes only. Not investment advice. Past performance does not guarantee future results.

Latest news

Factor Grades

5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.

Jade Biosciences Inc

Jade Biosciences Inc

Biotechnology·NASDAQ NMS - GLOBAL MARKET·US·IPO 2021-06-30
📅 Earnings
NASDAQ NMS - GLOBAL MARKETAfter-hours
Jade Biosciences Inc
Biotechnology
—
— (—)
Open
—
Prev close
—
Day range
— – —
52W range
$6.57 – $100.10
Mkt cap
$911.86M
P/E
—
EPS
$-5.40
Beta
1.06

Fundamentals

Valuation
Market Cap
$911.86M
P/E (TTM)
—S&P avg ~22
P/S (TTM)
—S&P avg ~2.8
P/B
2.13S&P avg ~4.5
P/FCF
—S&P avg ~26
EPS (TTM)
$-5.40
Book/sh
$6.74
Cash/sh
$6.82
Profitability
Gross Margin
—avg ~45%
Operating Margin
—avg ~15%
Net Margin
—avg ~12%
ROE
-46.55%avg ~18%
ROA
-42.99%avg ~7%
ROI
-46.55%
Payout Ratio
—
FCF/sh
—
Growth & Health
Rev Growth YoY
—
Rev Growth 5Y
—
EPS Growth YoY
—
EPS Growth 5Y
—
Current Ratio
—
Quick Ratio
20.33
Debt/Equity
—
LT Debt/Eq
—
Trading & Dividends
Beta
1.06
52W High
$100.10
52W Low
$6.57
Avg Vol (10D)
751.2K
Avg Vol (3M)
395.3K
Div Yield
0.00%
Div/sh (TTM)
—
Analyst
—
Price Performance
5D+10.64%
MTD+27.33%
3M+35.68%
6M+101.92%
YTD+15.94%
1Y-79.47%

Factor Grades

View details →
C
Overall score: 50/100
B-
Valuation
C
Growth
F
Profitability
B
Momentum
C
Financial Health
News will appear here once you add FINNHUB_API_KEY (free) to .env.local.
⚠️
Dilution risk detected

6 offering-related filings in the last 60 filings. Latest: 424B3 on 2026-03-06. View all →

Recent insider activity

View all →
  • 44
    Feb 13
  • 44
    Feb 13
  • 44
    Feb 13
  • 44
    Feb 13
  • 4OWNERSHIP DOCUMENT
    Oct 8